C. Chou, N. Vora, J.R. Li, W. Wang, Y. Yen, R. Ren, J. McDougall, C. Stand, B. Zhou, L. Weiss
{"title":"局部肿瘤的直流电化学治疗","authors":"C. Chou, N. Vora, J.R. Li, W. Wang, Y. Yen, R. Ren, J. McDougall, C. Stand, B. Zhou, L. Weiss","doi":"10.1109/ICBEM.1998.666374","DOIUrl":null,"url":null,"abstract":"To develop cancer electrochemical treatment (ECT) in the United States, we have conducted basic studies and started a Phase I clinical trial. Our in vivo preliminary results indicate that ECT is effective on RIF-I mouse tumor and rat fibrosarcomas. In the in vitro study ECT clearly demonstrated dose-dependent human oral carcinoma KB cell growth inhibition by colony-forming assay. We have started an animal study to resolve the ECT methodological problems for rat breast cancer. Meanwhile, we began a clinical trial treating patients with recurrent superficial measurable malignant tumors. Our goal is to make ECT a useful alternative method for treating localized tumors.","PeriodicalId":213764,"journal":{"name":"Proceedings of the 2nd International Conference on Bioelectromagnetism (Cat. No.98TH8269)","volume":"38 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1998-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Electrochemical treatment of localized tumors with direct current\",\"authors\":\"C. Chou, N. Vora, J.R. Li, W. Wang, Y. Yen, R. Ren, J. McDougall, C. Stand, B. Zhou, L. Weiss\",\"doi\":\"10.1109/ICBEM.1998.666374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To develop cancer electrochemical treatment (ECT) in the United States, we have conducted basic studies and started a Phase I clinical trial. Our in vivo preliminary results indicate that ECT is effective on RIF-I mouse tumor and rat fibrosarcomas. In the in vitro study ECT clearly demonstrated dose-dependent human oral carcinoma KB cell growth inhibition by colony-forming assay. We have started an animal study to resolve the ECT methodological problems for rat breast cancer. Meanwhile, we began a clinical trial treating patients with recurrent superficial measurable malignant tumors. Our goal is to make ECT a useful alternative method for treating localized tumors.\",\"PeriodicalId\":213764,\"journal\":{\"name\":\"Proceedings of the 2nd International Conference on Bioelectromagnetism (Cat. No.98TH8269)\",\"volume\":\"38 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the 2nd International Conference on Bioelectromagnetism (Cat. No.98TH8269)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/ICBEM.1998.666374\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 2nd International Conference on Bioelectromagnetism (Cat. No.98TH8269)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ICBEM.1998.666374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Electrochemical treatment of localized tumors with direct current
To develop cancer electrochemical treatment (ECT) in the United States, we have conducted basic studies and started a Phase I clinical trial. Our in vivo preliminary results indicate that ECT is effective on RIF-I mouse tumor and rat fibrosarcomas. In the in vitro study ECT clearly demonstrated dose-dependent human oral carcinoma KB cell growth inhibition by colony-forming assay. We have started an animal study to resolve the ECT methodological problems for rat breast cancer. Meanwhile, we began a clinical trial treating patients with recurrent superficial measurable malignant tumors. Our goal is to make ECT a useful alternative method for treating localized tumors.